Skip to main content

Coronavirus clinical trials at UC Health

2 in progress, 1 open to eligible people

Showing trials for
  • COVID-19 PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY)

    open to eligible females ages 13 years and up

    PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY) is a prospective cohort study of pregnant and recently pregnant women who are: either patients under investigation for COVID-19 or a confirmed case of COVID-19. Data from PRIORITY will be used to evaluate the impact of COVID-19 on the clinical course and pregnancy outcomes of pregnant women and women within 6 weeks of pregnancy.

    at UCLA UCSF

  • Outcomes Related to COVID-19 (Coronavirus) Treated with Hydroxychloroquine Among In-Patients with Symptomatic Disease

    Sorry, not currently recruiting here

    ORCHID is a multicenter, blinded, placebo-controlled, randomized clinical trial evaluating hydroxychloroquine for the treatment of adults hospitalized with COVID-19. Patients, treating clinicians, and study personnel will all be blinded to study group assignment.

    at UC Davis UCLA UCSF

Last updated: